Vital Access News

VWING 18 Month Patency and Infection Data Published in JVS

The VWING (Vital Access Corp, Salt Lake City, Utah) is a surgically implanted titanium device designed to facilitate cannulation of uncannulatable dialysis access arteriovenous fistulas (AVFs) because of excessive depth, aneurysm formation, or tortuosity but that exhibit sufficient flow volume to support hemodialysis. 18 month follow up data has been published in the Journal of Vascular Surgery demonstrating superior patency rates compared to elevations (91% at 18 months vs 59% at 24 months) and low infection rates (.014ppy).

View the Journal of Vascular Surgery Article here